Full-Time

Center Quality Specialist

Posted on 3/21/2026

LFB

LFB

1,001-5,000 employees

Public health biopharmaceuticals via plasma-derived products

No salary listed

Lake Worth, FL, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • High school diploma, GED or equivalent required.
  • Associates degree preferred or a minimum of three to six months quality or plasma industry experience required.
  • Strong verbal and written communication skills.
  • Proficiency with computers.
  • Explicit attention to detail.
  • Excellent analytical skills, organization skills, and follow-up.
  • Ability to read and interpret documents such as safety rules, operating and maintenance instruction, and procedure and technical manuals.
  • Ability to interpret a wide variety of technical instructions in mathematical or diagram form and deal with several abstract and concrete variables.
  • Physical requirements include use of hands to handle or feel objects, tools, or controls; reach with hands and arms; frequent leaning, bending, stooping, crouching, and reaching above the shoulders and below the knee; manual dexterity to perform all phases of donor plasmapheresis; ability to make and analyze a physical assessment of heart, lung sounds, signs of drug use, etc.; ability to stand for up to four hours at a time; ability to lift, tug, pull up to fifty pounds.
Responsibilities
  • Perform donor record file review.
  • Perform equipment quality control review - daily, weekly, monthly, semi-annual and annual.
  • Review medical reports and communication.
  • Perform reviews of equipment incidents.
  • Verification and release of sample shipment.
  • Responsible for the inspection and release of incoming supplies.
  • Initiate deviation reports as needed.
  • Perform weekly employee observations.
  • Assist the Manager of Quality Assurance with compliance of all state and federal regulations, FDA-approved Standard Operating Procedure Manual, Clinical Laboratory Improvement Amendments (CLIA), Current Good Manufacturing Practice (cGMP), Occupational Safety and Health Administration (OSHA), and internal company procedures.
  • Reviews the documentation of unsuitable test results and the disposition of the associated units.
  • Conduct root cause analysis for deviations and customer complaints, specifically in how they relate to the safety of the donor and the quality of the product.
  • Review of equipment records and donor system information, if applicable, to approve out of service equipment for use.
  • Review and approval of deferred donor reinstatement activities.
  • Review lookback information.
  • Waste shipment review.
  • Initiates investigations and reports any supplies that have not met quality specifications and requirements before use.
  • Review medical incident reports and documentation.

LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Courcebœufs, France

Founded

1994

Simplify Jobs

Simplify's Take

What believers are saying

  • ESCAPE strategy doubles bioproduction capacity by 2025.
  • Amber Plasma acquisition boosts Czech centers to 24.
  • Arras site triples medication production for patient demand.

What critics are saying

  • FDA bans cripple LFB USA rPRO™ proteins in 12-18 months.
  • CSL Behring squeezes Europlasma's 24 centers in 6-12 months.
  • Grifols captures 25% hemostasis share in 12-24 months.

What makes LFB unique

  • LFB specializes in plasma-derived medicines from 1994 French state initiative.
  • rPRO™ technology expresses recombinant proteins in transgenic animal milk.
  • Europlasma secures plasma via 24 Central European collection centers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Remote Work Options

Unlimited Paid Time Off

Flexible Work Hours

Paid Vacation

Hybrid Work Options

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

Conference Attendance Budget

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Education allowance

Tuition Reimbursement

Company News

MyPharma Editions
May 30th, 2024
LFB Acquires Amber Plasma in Czech Republic

Title: "LFB Acquires Amber Plasma in the Czech Republic" LFB and its subsidiary Europlasma have acquired Amber Plasma, which operates 12 plasma collection centers in the Czech Republic. This acquisition increases Europlasma's total to 24 centers in Central Europe, enhancing LFB's plasma collection capacity. The move supports LFB's goal to meet growing patient demand and will aid in the launch of a new production site in Arras, France, tripling its medication production capacity.

INACTIVE